![](/img/cover-not-exists.png)
A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer
Shiba, Eiichi, Yamashita, Hiroko, Kurebayashi, Junichi, Noguchi, Shinzaburo, Iwase, Hirotaka, Ohashi, Yasuo, Sasai, Kiyofumi, Fujimoto, TsukasaLanguage:
english
Journal:
Breast Cancer
DOI:
10.1007/s12282-015-0593-z
Date:
February, 2015
File:
PDF, 474 KB
english, 2015